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Neuronal Intranuclear Inclusions Minireview
in Polyglutamine Diseases:
Nuclear Weapons or Nuclear Fallout?
roles of the polyglutamine repeat proteins and their ag-
gregates in neurodegenerative disorders.
Neuronal Intranuclear Inclusions: Nuclear Beasts
or Molecular Roadkill?
A pathological hallmark of polyglutamine diseases is the
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presence of ubiquitin-positive intranuclear inclusions in
affected neurons of the CNS. Neuronal intranuclear in-
clusions (NIIs) were initially observed in mouse modelsAn increasing number of progressive neurodegenerative
of HD and SCA1, in which animals develop neurologicdiseases have been found to be caused by expanded
symptoms similar to those associated with their respec-CAG triplet repeats coding for variable length polyglu-
tive human disease (reviewed by Lunkes and Mendel,tamine stretches. All of the known polyglutamine repeat
1997; Ross, 1997; Davies et al., 1998). NIIs have subse-diseases, including Huntington's disease (HD) and sev-
quently been found in the brains of patients affectederal forms of the spinocerebellar ataxias, are character-
with HD, DRPLA, SCA1, and SCA3 (reviewed by Lunkesized by the loss of select populations of neurons. Excito-
and Mendel, 1997; Ross, 1997; Davies et al., 1998). Intoxicity, impaired energy metabolism, oxidative stress,
cases of HD, the increasing length of the polyglutamineand apoptosis (programmed cell death) have all been
tract appears to correlate with the increasing numberspostulated as general mechanisms of cell death op-
of NIIs (DiFiglia et al., 1997). While these aggregateserating in HD and other polyglutamine neurodegenera-
have been detected predominantly in the nucleus intive diseases. Increasing length of the glutamine repeat
SCA1 or in juvenile HD (DiFiglia et al., 1997; Skinner etin affected individuals strongly correlates with lower
al., 1997), they have also been observed in dystrophicages of onset (Gusella et al., 1997). In the past several
neurites and the cytoplasm, as well as the nucleus, inyears, identification of the causative genes coding for
the cortex and striatum of patients with adult-onset HDspecific target proteins has provided new opportunities
(DiFiglia et al., 1997). Cells transfected with mutant formsfor exploring the molecular mechanisms underlying the
of huntingtin, ataxin-1, or atrophin-1 also contain aggre-pathogenesis of polyglutamine repeat neurodegenera-
gates, although their properties appear to be somewhattive diseases, including huntingtin in HD, ataxin-1 in
different from those found in the animal models or brainsspinocerebellar ataxia type 1 (SCA1), ataxin-2 in SCA2,
of affected individuals. For instance, while ubiquitin-ataxin-3 in SCA3 (also known as Machado-Joseph dis-
positive aggregates were found to be almost exclusivelyease), ataxin-7 in SCA7, atrophin-1 in dentatorubral-
intranuclear in brains of patients with DRPLA and SCA3,pallidoluysian atrophy (DRPLA), and the androgen recep-
in cells transfected with atrophin-1 or ataxin-3 both peri-tor in spinobulbar muscular atrophy (SBMA) (reviewed by
nuclear and intranuclear aggregate bodies were ob-Gusella et al., 1997; Lunkes and Mendel, 1997; Ross,
served. In addition, while the aggregates found in the1997; Davies et al., 1998).
dentate nucleus of the cerebellum in DRPLA patientsAbnormal protein aggregation has been postulated to
were composed mainly of fine granular structures andexplain the molecular basis for many neurodegenerative
only occasional filamentous ones, atrophin-1-transfecteddiseases, including Alzheimer's disease (AD), Parkin-
cells consisted primarily of fibrous filaments (Paulsonson's disease, and prion diseases. Prior to the discov-
et al., 1997; Igarashi et al., 1998). It is also noteworthyery of polyglutamine aggregates in vivo, in vitro studies
that while in patients NIIs were only detected in thehave suggested that expanded polyglutamine-containing
subpopulation of neurons that were affected in each ofprotein fragments form aggregates more readily than
these diseases, they could be found experimentally infragments containing nonexpanded glutamine residues.
many types of cultured cells. Thus, it appears that multi-This has been proposed to occur either by the mecha-
ple factors, including cell type and level of expression,nism of transglutaminase-catalyzed cross-linking (Kah-
may regulate a cell's susceptibility to form aggregates,lem et al., 1996) or by polar-zipper hydrogen bonding
as well as the form and subcellular localization of these(Perutz et al., 1994). Proteolytic cleavage of huntingtin
aggregates.specifically containing the pathogenic polyglutamine
The most pressing question regarding the presenceexpansion has been shown to lead to the formation of
of the polyglutamine-containing aggregates in the CAGinsoluble aggregates, with tinctorial staining properties
repeat disorders is whether they, and particularly NIIs,similar to those of the potentially neurotoxic b-amyloid-
are pathogenic agents or simply markers of the cell'slike fibrils observed in AD (Scherzinger et al., 1997).
demise. In a recent paper in Cell, Saudou et al. (1998)
This has raised the question of whether conformational
have shown that apoptotic neuronal cell death of cul-
changes imparted by the expanded polyglutamine tract
tured striatal neurons transfected with mutant huntingtin
lead to the formation of insoluble aggregates with
can be prevented by coexpression of the antiapoptotic
b-sheet structure, which like b-amyloid might be toxic to
gene bcl-XL, by treatment with the caspase-3 inhibitor
selective neurons. Several recent studies have provided
Ac-DEVD-CHO, or by supplementing with the neuro-
valuable new clues regarding the potentially neurotoxic trophins brain derived neurotrophic factor (BDNF) and
ciliary neurotrophic factor (CNTF). Interestingly, while
Ac-DEVD-CHO prevented apoptosis, it failed to sup-* To whom correspondence should be addressed (e-mail: tanzi@
helix.mgh.harvard.edu). press the formation of NIIs, evidence that the formation
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of detectable NIIs may not be a sufficient event for neu- were observed in these mice, suggesting that nuclear
ronal cell death mediated by mutant huntingtin. localization of ataxin-1 is required for Purkinje cell neu-
In an elegant study in a recent issue of Cell, Klement ropathogenesis, the onset of neurologic symptoms, and
et al. (1998) assessed the role of ataxin aggregates in NII formation in the SCA transgenic mice. Thus, nuclear
the SCA1 disease process. Transgenic mice expressing translocation, but not the formation of detectable nu-
an ataxin-1 construct in which a previously described clear inclusions, is required to induce neuronal apopto-
self-association region was deleted were shown to de- sis by mutant huntingtin in cultured striatal neurons
velop ataxia and Purkinje cell pathology in the absence (Saudou et al., 1998) or to develop neuropathogenesis
of NIIs, again suggesting that NIIs are not a necessary by mutant ataxin-1 in SCA transgenic animals (Klement
prerequisite for pathogenesis. Together, the data from et al., 1998). Although translocation of the mutant protein
Klement et al. (1998) and Saudou et al. (1998) suggest to the nucleus is a critical step for pathogenesis, it is
that detectable NIIs are more akin to nuclear ªfalloutº questionable as to whether inhibition of nuclear trans-
as opposed to constituting a nuclear ªthreat.º port will ultimately be useful for providing a potential
NIIs found in all polyglutamine diseases have been means for therapeutic intervention, as it may interfere
demonstrated to be ubiquitin positive (Lunkes and Man- with the normal function of these and other proteins,
del, 1997; Ross, 1997; Davies et al., 1998). A recent study like ataxin-1, that are normally targeted to enter the
showed that the proteasome and folding chaperone nucleus.
HDJ-2/HSDJ colocalized with ataxin-1 aggregates in af- Caspase-Mediated Proteolysis in Polyglutamine
fected neurons of SCA1 patients and transgenic mice, Disorders: First Strike or Aftermath?
and that ataxin-1 aggregates were reduced by the over- Although the actual mechanism of cell death induced
expression of HDJ-2/HSDJ in HeLa cells (Cummings et by expanded polyglutamine repeats remains unresolved,
al., 1998). These data suggest that formation of ubiqui- the nuclear presence of the expanded protein is clearly
tin-positive NIIs may be associated with an ataxin-1- instrumental in pathogenicity. Because nuclear fractions
mediated perturbation in proteasome function and/or isolated from brains of HD patients contain only trun-
misfolding and subsequent aggregation of ataxin-1- cated polyglutamine-containing fragments of the N-ter-
containing expanded polyglutamine tracts (Cummings minal region of huntingtin (DiFiglia et al., 1997), two pos-
et al., 1998). A potential link between dysfunctional pro- sibilities present themselves: (1) only proteolytically
teasome-mediated catabolism and mutant huntingtin processed fragments containing the pathogenic ex-
has been previously implicated by the finding that hun- panded glutamine tracts are transported to the nucleus,
tingtin interacts with HIP2, a 25 kDa E2 ubiquitin-conju-
and (2) the full-length mutant protein is first translocated
gating enzyme (Kalchman et al., 1996). Thus, both hun-
into the nucleus and then subjected to proteolytic pro-
tingtin and ataxin-1 have been linked to perturbations
cessing or ubiquitin-dependent degradation, althoughin proteasome function, raising the question of whether
the expanded polyglutamine-containing N-terminal re-this leads to NII formation and/or enhanced cell death.
gion remains resistant to degradation. In any case, itIn the recent report by Saudou et al. (1998), cotransfec-
remains important to determine whether nuclear local-tion of plasmids encoding mutant huntingtin and a domi-
ization and/or its consequences require proteolyticnant negative form of the ubiquitin-conjugating enzyme
cleavage as an initial step and, if so, to identify whichled to enhanced cell death but markedly decreased the
proteases are involved.occurrence of the NIIs. Surprisingly, this indicates oppo-
Several gene products associated with polyglutaminesitional effects of proteasomal inhibition on NII formation
disorders, including huntingtin (Goldberg et al., 1996),and neuronal survival. These observations support the
atrophin-1 (Miyashita et al., 1997), ataxin-3, and the an-notion that NIIs do not directly compromise neuronal
drogen receptor (Wellington et al., 1998) have beenviability.
shown to be cleaved by caspases, cysteine proteasesNuclear Entry: the Road to Death?
that are activated during apoptosis. Caspase-mediatedIt is puzzling why huntingtin, a cytoplasmic protein, ac-
cleavage of these proteins generate N-terminal truncatedcumulates in the nucleus. Both Saudou et al. (1998) and
proteins containing expanded polyglutamine tracts thatKlement et al. (1998) have data linking nuclear localiza-
might then be prone to form aggregates and/or contrib-tion to cell death. Saudou, Greenberg, and colleagues
ute to cell death. Along these lines, caspases might beexamined whether the entry of huntingtin into the nu-
activated by mutant polyglutamine proteins themselvescleus is a necessary step for initiating neuronal apopto-
or by their cellular decompartmentalization (e.g., trans-sis in neuronal cells expressing mutant huntingtin. The
location to the nucleus), and the activated caspasesexpression of mutant huntingtin containing a nuclear
would then cleave these proteins during the ªeffectorº orexport signal (NES) in striatal neurons inhibited the for-
ªexecutionº stage of apoptotic cell death. Alternatively,mation of NIIs; this could be reversed by treatment with
caspase cleavage of these proteins may merely be athe nuclear export inhibitor leptomycin B. When forma-
secondary consequence of the apoptotic cell death pro-tion of NIIs was inhibited by expression of mutant hun-
cess. In either case, it is important to determine whethertingtin containing an NES, neuronal apoptosis was also
caspase-cleaved products (e.g., truncated huntingtin)blocked completely.
more readily form aggregates (e.g., NIIs) and whetherSimilar results were found in a mouse model of SCA1.
the cleaved products influence the rate of cell death.In contrast to huntingtin, ataxin-1 is normally localized
The new data from Saudou et al. (1998) show that theto both the nucleus and cytoplasm, and it contains a
the formation of NIIs does not appear to require cleavagenuclear localization sequence (NLS) (Klement et al.,
by an Ac-DEVD-CHO-sensitive caspase, at least for hun-1998). Klement, Orr, and colleagues created mice ex-
tingtin (see above). Nevertheless, it remains importantpressing ataxin-1 with a mutated NLS. As a result, nei-
ther significant ataxia nor severe Purkinje cell pathology for future studies to delineate the temporal order of
Minireview
659
caspase activation, aggregate formation, and cell death. However, it should be noted that a potentially neuro-
pathogenic role for smaller submicroscopic aggregatesAlong similar lines, it will also be critical to determine
whether caspase cleavage is required for nuclear trans- has not been ruled out in these recent studies. Although
b-amyloid is considered to be a neurotoxic agent in AD,location.
Interacting Proteins: Dangerous Liaisons? it is also conceivable that cellular decompartmentaliza-
tion of its precursor, APP, may be more detrimental toDespite the widespread expression of the polyglutamine
disease±associated proteins, only select neurons are cell function than are Ab aggregates. Finally, the issue
of whether caspase cleavage of these proteins is a pri-affected while others are spared in their respective dis-
orders. Many interacting proteins for huntingtin and mary or secondary event in the neurodegenerative pro-
cess remains to be resolved. Future experimentationother polyglutamine disease proteins have now been
identified (reviewed by Gusella and MacDonald, 1998), elucidating the relationships between expanded poly-
glutamine repeats and potential gain-of-function effectsalthough their cellular distributions do not strictly corre-
late with the pathological profiles of these diseases. on protein trafficking, processing (e.g., caspase cleav-
age), and aggregation should greatly benefit our under-The aberrant interaction of mutant proteins with specific
partners in selective neuronal populations has been pro- standing of the molecular basis of these and other re-
lated neurodegenerative disorders.posed to play a role in determining cell-specific vulnera-
bility in the polyglutamine diseases (Gusella and Mac-
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